Charles River Laboratories International Inc

Iconic Profile

Charles River Laboratories International Inc (CRL) is a leading provider of essential services and products to the pharmaceutical and biotechnology sectors, specializing in preclinical and clinical laboratory services. With a market capitalization of $10.5 billion, CRL plays a crucial role in the drug development process, offering a comprehensive range of solutions including research models, laboratory services, and regulatory consulting. The company is well-positioned in the Life Sciences Tools & Services sector, benefiting from the growing demand for innovative therapies and the increasing complexity of drug development. CRL's expertise and extensive portfolio enable it to support clients in accelerating their research and development efforts, thereby contributing to advancements in healthcare and improving patient outcomes. Its strategic focus on quality and compliance further solidifies its reputation as a trusted partner in the life sciences industry.